logo
China's EV race to the bottom leaves a few possible winners

China's EV race to the bottom leaves a few possible winners

CNBC08-06-2025
China's electric car price war shows little sign of letting up, putting more pressure on companies to survive. Tesla 's China sales fell by 15% in May from a year ago, China Passenger Car Association data showed. BYD , in contrast, reported a 14% year-on-year sales increase as it held onto first place in the market by volume, but even it had to announce sharp discounts as sales growth slowed from April's pace. "We expect additional price competition in the coming weeks as BYD is still lagging behind its sales target," said a team of analyst led by CLSA analyst Xiao Feng in a report Wednesday. While the analysts still have a high conviction, with an outperform rating on BYD's Hong Kong-listed shares, they see Geely as the 'best positioned" for investors as it is striking the optimal balance with its internal business structure and competing on vehicle price. CLSA has a price target of 483 Hong Kong dollars ($61.55) on BYD, and a 23 HKD target on Geely, also listed in Hong Kong. That's upside of nearly 20%, and 28%, respectively, from Friday's close. Geely is a large conglomerate with electric vehicle brands Galaxy, Zeekr and Lynk and Co., which share some of the same tech and manufacturing systems. "Geely's Galaxy NEV brand has successfully targeted BYD's popular models with better specs and lower prices," Macquarie analysts said in a report Thursday, citing a call with an auto dealer who manages dealerships for BYD, Geely and Xpeng in the relatively affluent Suzhou region near Shanghai. "The expert believes Geely's success will continue, as it is still ramping up new models to compete with BYD's entire model line-up," the report said. The Macquarie analysts have a price target of 22 HKD on Geely and rate the stock outperform. But they like U.S.-listed electric car startup Xpeng even more, with a $24 price target. Xpeng is likely to benefit from near-term market share gains given its advanced driver assist system and upcoming car models, the analysts said. The latest delivery data showed Xpeng delivered more than 30,000 cars in May for a seventh straight month, a rare feat among its immediate peers. The company last month also launched a new car under its lower-priced Mona brand. Among publicly listed new energy vehicle companies, a category that includes battery-only and hybrid-powered cars, Leapmotor and Li Auto have proven relatively stable, each with deliveries of more than 40,000 vehicles in May. Both companies have Hong Kong listings, while Li Auto also trades in New York. "Through a continuously expanding product matrix and cost-effective models, Leapmotor has achieved a stable market share in the Chinese mass EV market and has strong growth potential," the CLSA analysts said. They have a price target of 72 HKD, or more than 30% upside from Friday's close. Leapmotor reported a net loss in the first quarter, however, compared with profit in the fourth quarter. But Li Auto maintained profitability in the first quarter, according to results released on May 29. "We still see ample upside as a better-than-feared 1Q should inspire investor conviction about sequential recovery in 2Q," Morgan Stanley analysts said in a May 29 report. They have a price target of $36, for upside of more than 20% from Thursday's close. "The management team has found its pace for a steady and solid comeback, underpinning a more material resurgence of volume/margins into 2H25 amid new model launches," the analysts added. "Li Auto's premium model lineup can steer clear of the fierce pricing competition in the mass market." Li Auto is best known for its SUVs that come with a gas tank for extending the battery's driving range. Prices start around 244,000 yuan ($34,000). Industry giant BYD in contrast now sells some cars at 55,800 yuan, with most models falling in the 100,000 yuan to 200,000 yuan price range. The company also has a high-end sub-brand called Yangwang, which prices cars at well above 1 million yuan. Analysts that still like the stock see potential in BYD's overseas expansion. The narrative on BYD among European investors "sounds more optimistic," contrary to more cautious sentiment in China following the automaker's recent price promotions, JPMorgan's Nick Lai, head of Asia Pacific auto research said in a report Wednesday. Lai and his team also cited conversations with senior BYD management in London in the last week. "All in all, we retain our long-term positive view on the company and believe the (earnings) contribution from the overseas market and BYD's premium portfolio will increasingly play an important role," the JPMorgan analysts said. "We estimate that BYD's overseas business and premium brands will together contribute over 40% of its vehicle earnings in 2025 (up from 20-25% last year) even though they account for only about 20% of volume." The analysts rate BYD overweight, with a price target of 600 HKD. However, the risk of a flood of cheap cars into markets such as Europe have prompted tariff increases. In China, official commentary is also sounding the alarm about excessive competition. "We believe an end to the current price war will come down to simple economics," the Macquarie analysts said, pointing out that production capacity for both electric and traditional vehicles is more than 50 million units, well above the annual wholesale volume of 25 million to 27 million vehicles. "Thus, the market will likely stabilize either via higher demand or right-sized capacity and consolidation," the analysts said. "We believe this may take at least another three to five years." — CNBC's Michael Bloom contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2
Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2

Business Insider

timean hour ago

  • Business Insider

Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2

Billionaire investor David Tepper increased his stake in the struggling health insurance giant, UnitedHealth (UNH), during Q2. His move mirrors Warren Buffett 's Berkshire Hathaway (BRK.B), which also revealed a new $1.57 billion stake in UNH stock. Further, Michael Burry's Scion Asset Management bought calls on 350,000 shares. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. UNH stock gained 14% on Friday as bullish bets from Top hedge funds boosted investor hopes for a rebound. According to a recent 13F filing, Tepper's Appaloosa Management LP added 2.3 million shares of UNH, bringing the total value of the stake to $764 million. This makes UNH the fund's second-largest holding after Chinese e-commerce giant Alibaba (BABA). Tepper's bet comes at a turbulent time for UnitedHealth, which is dealing with a criminal probe into Medicare billing, a CEO shakeup, and the aftermath of a massive cyberattack. UNH stock has plunged about 40% year-to-date. Tepper Shifts Strategy on China Tepper's bet on UNH aligns with his investment strategy, which involves making bold bets on companies that others are avoiding. It is similar to his earlier investment in Chinese stocks, which he began buying last year when many investors were pulling back over economic and geopolitical concerns. It must be noted that those investments paid off as China's MSCI benchmark surged 46% over the past year due to Beijing's economic stimulus efforts. However, Tepper is now taking a more cautious approach. The fund reduced its holdings in major Chinese companies amid rising trade tensions. Appaloosa cut its stake in Alibaba by over 20% and also trimmed its positions in (JD), Baidu (BIDU), and PDD Holdings (PDD). Tepper's Other Bullish Bets Apart from UNH, the investor also ramped up his stake in Nvidia (NVDA), adding 1.45 million shares for a total of 1.75 million. This 483% increase brings the position's value to over $276 million. Also, he made some notable new investments last quarter. These include tech giant Intel (INTC), with 8 million shares valued at $179.2 million, and aerospace and defense company RTX (RTX), with 585,000 shares worth $85.4 million. The third-largest new buy is health information technology and clinical research provider IQVIA Holdings (IQV), with 300,000 shares valued at $47.3 million. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, four Holds, and two Sells assigned in the last three months. At $312.65, the average UnitedHealth stock price target implies a 2.17% upside potential.

‘Joyride Might Be Over,' Says Top Investor About Nvidia Stock
‘Joyride Might Be Over,' Says Top Investor About Nvidia Stock

Business Insider

time3 hours ago

  • Business Insider

‘Joyride Might Be Over,' Says Top Investor About Nvidia Stock

Nvidia (NASDAQ:NVDA) stock has built a reputation for consistently shattering quarterly earnings projections – a fact seasoned investors know all too well. But that winning streak can be a double-edged sword, as even a solid beat doesn't always translate into immediate post-earnings gains. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. That dynamic makes Nvidia's upcoming fiscal Q2 2026 earnings on August 27 especially intriguing. Momentum is already firmly in the bulls' corner, with NVDA shares up 91% since hitting a trough in early April. Expectations remain strong, though not at the triple-digit pace NVDA has delivered in its best quarters. The average analyst estimate of $45.75 billion points to year-over-year growth of 52.31%, with margins expected to hold at an impressive 72%. On paper, such results could still tempt investors to add shares ahead of the report – even if history suggests a short-term lull is possible afterward. But not everyone is convinced. One top investor, known as Oakoff Investments, is taking a far more cautious stance. 'I don't like the setup formed in NVDA's price action as it approaches the Q2 earnings release date,' warns the 5-star investor, who is among the top 4% of TipRanks' stock pros. Oakoff's caution stems largely from concerns about Nvidia's sales to China. While previous U.S. restrictions appear to have been lifted, there are signs the Chinese government may impose its own limits. That also possibility raises the stakes for Nvidia to deliver outsized growth in other regions to sustain investor enthusiasm – a task Oakoff believes is becoming increasingly difficult. 'If the market gets a slight hint towards further deterioration on this front, the stock may sell off badly even if NVDA beats the headline numbers as strongly as it did during the past 2 years,' Oakoff opined. Valuation is another sticking point. After months of gains, Oakoff argues the rally has been fueled by multiple expansion, pushing NVDA's Forward P/E ratio to an 'unsustainable' 42.5x. The result, according to Oakoff, is a setup vulnerable to disappointment. Given these risks, the investor is leaning toward profit-taking before the earnings call. 'I maintain a Hold rating, believing NVDA stock's high valuation and the new China uncertainty outweigh the likelihood of a strong Q2 beat,' Oakoff says. (To watch Oakoff Investments' track record, click here) Wall Street, in contrast, remains almost 'all in' on NVDA. With 35 Buys, 3 Holds, and a solitary Sell rating, the stock enjoys a Strong Buy consensus rating. (See NVDA stock forecast) To find good ideas for AI stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store